Colleges
Websites
-
BHF
British Heart Foundation
-
OCMR
Oxford Centre for Clinical Magnetic Resonance Research
-
Oxford - BHF 4-year Graduate Programme
Oxford - BHF 4-year Graduate Training Scheme
-
Oxford DTC
The University of Oxford Doctoral Training Centre
-
Interdisciplinary Biosciences DTP
Oxford Interdisciplinary Biosciences Doctoral Training Programme
-
Oxford-Nottingham Biomedical Imaging CDT
Oxford-Nottingham Biomedical Imaging Centre for Doctoral Training
Damian Tyler
Professor of Physiological Metabolism
- RDM Director of Graduate Studies
I am currently the Director of MR Physics at the Oxford Centre for Clinical Magnetic Resonance Research (OCMR) and a Fellow in Medicine at Somerville College.
I have been based in Oxford since 2001 and have more than 20 years experience in the development and application of Magnetic Resonance Imaging and Spectroscopy (MRI/MRS). I gained my MSci in Medical Physics in 1998 and my doctorate in 2001, both from the University of Nottingham. I am an associate member of the Cardiac Metabolism Research Group (CMRG) and lead the Oxford Metabolic Imaging Group.
My research in Oxford has been based on the study of cardiac structure, function and metabolism in normal and diseased hearts using MRI/MRS. This has included developing techniques using high spatial and temporal resolution CINE imaging to assess heart function and localized phosphorus and carbon spectroscopy to monitor and investigate abnormalities of metabolism. I was awarded British Heart Foundation Intermediate and Senior Research Fellowships to develop the technique of Dynamic Nuclear Polarization (DNP) for application to the study of cardiac metabolism in the human heart. A fundamental limitation of magnetic resonance is its low sensitivity, but the recently developed technique of DNP provides a practical method to gain up to 10,000-fold increases in sensitivity in molecules with an in vivo stability of approximately one minute. This has enabled visualization of 13C-labelled cellular metabolites in vivo and, more importantly, their enzymatic transformation into other species. This is an important development that could revolutionize spectroscopy using MR.
Key publications
Noninvasive In Vivo Assessment of Cardiac Metabolism in the Healthy and Diabetic Human Heart Using Hyperpolarized 13C MRI
Journal article
Rider OJ. et al, (2020), Circulation Research, 126, 725 - 736
Noninvasive immunometabolic cardiac inflammation imaging using hyperpolarized magnetic resonance
Journal article
Lewis AJM. et al, (2018), Circulation Research, 122, 1084 - 1093
Increasing pyruvate dehydrogenase flux as a treatment for diabetic cardiomyopathy: A combined 13C hyperpolarized magnetic resonance and echocardiography study
Journal article
Page LML. et al, (2015), Diabetes, 64, 2735 - 2743
Hyperpolarized magnetic resonance: A novel technique for the in vivo assessment of cardiovascular disease
Journal article
Schroeder MA. et al, (2011), Circulation, 124, 1580 - 1594
In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance
Journal article
Schroeder MA. et al, (2008), Proceedings of the National Academy of Sciences of the United States of America, 105, 12051 - 12056
Recent publications
Feasibility of multimodal metabolic analysis for detecting early changes in acute neuroinflammation
Journal article
Grist JT. et al, (2026), Journal of Neuroinflammation, 23
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes
Journal article
Hundertmark MJ. et al, (2026), Circulation, 153, 550 - 563
A pilot study on protocol consistency and graph metric reproducibility in microstructure-weighted connectomes
Journal article
Cavallo M. et al, (2026), Scientific Reports, 16
Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy
Journal article
Anderson S. et al, (2026), Nature Cardiovascular Research, 5, 138 - 154
Changes in the Metabolome of Different Tissues in Response to Streptozotocin Diabetes and Mildronate Exposure: A Metabolomic Assessment
Journal article
Hauton D. et al, (2026), Metabolites, 16
